Arrakis Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 68
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $75M
Latest Deal Amount
  • Investors
  • 15

Arrakis Therapeutics General Information

Description

Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform integrates RNA bioinformatics, chemical biology tools, chemical and biological assays, and RNA-directed medicinal chemistry, enabling physicians to treat a range of diseases including neurology, oncology, and rare genetic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 828 Winter Street
  • Waltham, MA 02451
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrakis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 10-Apr-2019 $75M 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Mar-2017 000.00 000.00 0000 Completed Generating Revenue
1. Seed Round 01-Jan-2015 $2M $2M Completed Startup
To view Arrakis Therapeutics’s complete valuation and funding history, request access »

Arrakis Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Arrakis Therapeutics’s complete cap table history, request access »

Arrakis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform i
Drug Discovery
Waltham, MA
68 As of 2021
00000
0000 0000-00-00
00000000000 00000

000000 0

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
South San Francisco, CA
00 As of 0000
00000
0000000 0000 00000

0000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
000000000000000
Hannover, Germany
00 As of 0000
000.00
00000 00000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arrakis Therapeutics Competitors (60)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amunix Pharmaceuticals Private Equity-Backed South San Francisco, CA 00 00000 0000000 0000 00000
0000000 Venture Capital-Backed Hannover, Germany 00 000.00 00000 00000 000.00
0000000000000 Corporation Shelton, CT 00 000.00 000000000 000.00
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
000000000 00000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
You’re viewing 5 of 60 competitors. Get the full list »

Arrakis Therapeutics Executive Team (12)

Name Title Board Seat Contact Info
Jacques Dumas Ph.D Chief Scientific Officer
Jennifer Petter Ph.D Co-Founder & Chief Innovation Officer
James Barsoum Ph.D Senior Vice President of Biology
Erik Spek Ph.D Vice President, Legal and Intellectual Property
Heather Lounsbury Vice President of Business & Technical Operations
You’re viewing 5 of 12 executive team members. Get the full list »

Arrakis Therapeutics Board Members (15)

Name Representing Role Since
Alan Walts Ph.D Arrakis Therapeutics Board Observer 000 0000
Carolyn Green Self Board Member 000 0000
Colleen Cuffaro Ph.D Canaan Partners Board Member 000 0000
Elaine Jones Ph.D Pfizer Ventures Board Observer & Board Member 000 0000
Jakob Loven Ph.D Nextech Invest Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Arrakis Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arrakis Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »